secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0000950170-21-002405
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mednax reports Q3 GAAP EPS $0.37 from continuing ops, revenue $493M, adjusted EPS $0.46
--------------------------------------------------------------------------------

- Net revenue $492.9M, up 7% YoY; same-unit revenue +5.9%, driven by 6.5% volume increase.
- GAAP EPS $0.37 vs loss $0.03 prior year; Adjusted EPS $0.46 vs $0.37.
- Adjusted EBITDA $73.4M vs $72.8M; no CARES Act funds in Q3 2021 vs $14.2M in Q3 2020.
- Used $20M to invest in Brave Care; redeemed $750M 5.25% notes in Jan; cut revolver to $600M from $1.2B.
- Cash at Sep 30: $358M; net debt $642M; no debt on revolver.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/0000950170-21-002405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/md-20211028.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-002405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer